EHC:NYE-Encompass Health Corp (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 92.06

Change

-0.39 (-0.42)%

Market Cap

USD 9.38B

Volume

0.58M

Analyst Target

USD 86.07
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 105.82B
THC Tenet Healthcare Corporation

N/A

USD 15.44B
UHS Universal Health Services Inc

N/A

USD 13.69B
DVA DaVita HealthCare Partners Inc

N/A

USD 11.58B
CHE Chemed Corp

N/A

USD 7.97B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 2.08B
AMN AMN Healthcare Services Inc

N/A

USD 1.11B
BKD Brookdale Senior Living Inc

N/A

USD 1.10B

ETFs Containing EHC

SSPX Janus Henderson U.S. Sust.. 3.33 % 0.00 %

N/A

USD 8.12M
XHS SPDR® S&P Health Care Se.. 2.18 % 0.35 %

N/A

USD 0.08B
HLTH:AU VanEck Global Healthcare .. 2.11 % 0.00 %

N/A

USD 0.06B
OUSM 2.07 % 0.48 %

N/A

N/A
JPSV Jpmorgan Active Small Cap.. 1.96 % 0.00 %

N/A

USD 0.02B
RNMC 0.00 % 0.60 %

N/A

N/A
GLRY Inspire Faithward Mid Cap.. 0.00 % 0.00 %

N/A

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.98% 70% C- 93% A
Dividend Return 0.45% 33% F 8% B-
Total Return 38.43% 70% C- 93% A
Trailing 12 Months  
Capital Gain 31.10% 57% F 79% B-
Dividend Return 0.85% 33% F 10% F
Total Return 31.96% 57% F 77% C+
Trailing 5 Years  
Capital Gain 43.28% 61% D- 68% D+
Dividend Return 7.10% 57% F 22% F
Total Return 50.38% 67% D+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 5.77% 41% F 59% D-
Dividend Return 7.11% 45% F 55% F
Total Return 1.34% 75% C 30% F
Risk Return Profile  
Volatility (Standard Deviation) 24.16% 91% A- 43% F
Risk Adjusted Return 29.42% 50% F 48% F
Market Capitalization 9.38B 81% B- 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.